MODERNA INC. DL-,0001/ US60770K1079 /
6/5/2024 9:52:16 PM | Chg. +9.240 | Volume | Bid9:59:59 PM | Ask9:59:59 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
142.380EUR | +6.94% | 2,297 Turnover: 316,062.380 |
142.340Bid Size: 351 | 142.420Ask Size: 351 | 54.59 bill.EUR | - | - |
GlobeNewswire
6/5
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - ...
GlobeNewswire
5/22
Oruka Therapeutics Expands Leadership Team with Appointment of Industry Veterans Drs. Joseph Senn an...
GlobeNewswire
5/12
TrialWire Patient Recruitment Platform that Reboots Stalled Clinical Trials announced as Multi-Award...
GlobeNewswire
5/8
CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
5/8
Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Bi...
GlobeNewswire
5/2
Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
5/1
Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems
GlobeNewswire
5/1
CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clin...